Jefferson County Syringe Exchange Program (SEP) Annual Report 2017

Similar documents
Targeted Outreach & Other Strategies for Increasing HCV Testing

SYRINGE SERVICES PROGRAMS IN INDIANA

Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department

High Impact Prevention for People Who Inject Drugs. June 30, 2015

Needle Exchange Programs

Syringe Exchange Program Plan

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

UNDERSTANDING SYRINGE EXCHANGE IN UTAH. Amelia Prebish, MPH Heather Bush, BS Mindy Vincent, LCSW

Jefferson Healthcare Rural Health Dental Clinic

who use drugs in order to assist them in reducing harm while in the cycle of addiction

Operational Guideline

Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004

Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another?

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

Albuquerque Health Care for the Homeless (AHCH)

Syringe Exchange/Harm Reduction Program Mid-Year Report

Needle and syringe distribution

Harm Reduction and Syringe Exchange Programs in the City and County of Los Angeles

Harm Reduction at Lummi Tribal Health Center. Jessica Rienstra RN

Local Legislative Approval and Program Certification

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.

Guidelines For Services Providing Injecting Equipment

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Unique Programs to Address Drug User Health

Washington State PMP Data Mapping Project

Syringe Exchange Programs December 2005

Innovative Ways to Fund Harm Reduction Services New Mexico

Meeting People Where they Are: Hepatitis C, Wound care and Syringe Access. Heather Lusk, MSW

PORT GAMBLE S KLALLAM TRIBE. Tribal Opioid Response Plan

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Prevention Point Philadelphia

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT

Mapping Opioid and Other Drug Issues (MOODI) Tool. Washington State Category 3 Grant BJA Meeting August 2016

What s The Harm? Conference 2015: Where are we now.what s Next? Beth Whalen

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

Transmission/Prevention

CPAA Opioid Response Workgroup Meeting

Historical Perspectives

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

Advocating for Sensible Policies in the Age of HCV Cure

LIFEPOINT Outreach & Syringe Exchange Program

Interior AIDS Association

Initiating Conversations to Reduce Harm Across Care Settings: Healthcare Opportunities

Drug Use, Harm Reduction, and HIP

TITLE NALOXONE STATEWIDE STANDING ORDER UPDATE & NARCAN ACCESS ONE-DAY EVENT

OPIOIDS: Are We Making The Grade? December 1, :30am 3:15pm Olympic Medical Center Linkletter Hall

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Syringe Exchange Research Update Harm Reduction Coalition August 2008

SECTION IV: IDU Syringe Exchange Data

Tips For A Safer Injection

Prevention and Risk Reduction Programs & Services in Saskatchewan

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Hepatitis C Best Practice Guidelines For Local Health Departments

IMPORTANT HEALTH INFORMATION

Ryan White Programs Provision of Substance Use Treatment

Potential Solutions to Epidemic Substance Abuse in US and Europe

HIV Prevention Service Provider Survey 2014

Advocating for Syringe Exchange Programs

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

QuADS Organisational Standards and Professional Competencies in needle exchange

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Amanda Archer, BS, MPH

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016)

Steve Alsum. The Grand Rapids Red Project (616)

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

National HIV Behavioral Surveillance Portland, Oregon

Prevention of and Immunisation against Hepatitis B and C

Request for Proposals for a Clean Syringe Exchange Program

Ventura County Opioid Solutions Summit Preventing Accidental Overdose: NO O.D. Overdose Prevention Project August 29, 2017

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE

Take Home Naloxone elearning Module Script

FY2019 Labor, Health and Human Services, Education Appropriations Summary

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Slide 1. Slide 2. Slide 3. What is injection safety Safe injection practices- Blood glucose monitoring Sharp safety.

Narrative Science-based literature on Syringe Exchange Programs (SEPs)

OVERVIEW. NCHRC Harm Reduction Pills Ingestion to Smoking/Injecting Harm Reduction Legislation, Services and Advocacy Ban the Box/Fair Hiring LEAD Q+A

Addressing the Opioid Epidemic in Tennessee

HCSP TRAINING MANUAL

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

Testing, Prevention and Care IDU in Chicago, 2009

OPIOID WORKGROUP LEADERSHIP TEAM

Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs

Presented by: Carol Strike, PhD, Associate Professor at the Dalla Lana School of Public Health, University of Toronto.

SPEEDBALLS INJECTING HEROIN & CRACK (OR COCAINE)

Evaluations. Viewer Call-In. Guest Speakers. What s New in AIDS/HIV? Phone: Fax: Thank You to our Sponsors

Journal Club: Naloxone Programs in the Community and Their Success to Decrease Overdoses from Opioids

HepTalk Listserv Archive August 2005

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Five Things the Family Physician Needs to Know about Addiction and Harm Reduction

REPORT ON EXPLORATORY SITE VISITS FOR COMPREHENSIVE USER ENGAGEMENT SITE (CUES)

Workforce Safety for Syringe Services Programs (SSP)

ANSWER: There are 18 medicine drop box locations in Lehigh County and 23 medicine drop box locations in Northampton County.

FIDGET CUBE / SPINNER HAVE A BREAK WATER

Produced by La Direction des communications du ministère de la Santé et des Services sociaux

Transcription:

615 Sheridan Street Port Townsend, WA 98368 www.jeffersoncountypublichealth.org Jefferson County Syringe Exchange Program (SEP) Annual Report Jefferson County Public Health has provided a Syringe Exchange Program (SEP) since 2000 to reduce the risk of HIV and other blood-borne infections among injection drug users (IDU), their families, and communities. SEP services include access to clean syringes, disposal of used syringes, prevention materials, risk reduction education, naloxone overdose prevention, and referral services. Education includes information on HIV, hepatitis, STDs, overdose prevention, encouraging one time use of needles, health alerts (for example, wound botulism and recent heroin overdoses/deaths), and immunizations. Internal referrals include, HIV, hepatitis C, and STD screening, family planning, tuberculosis screening, and immunizations. External referrals include drug and alcohol treatment, medical care, dental care, mental health care, domestic violence, food, clothing, and shelter. State HIV prevention dollars partially funded the SEP from 2000 2011. CDC guidelines shifted in 2011, focusing HIV Prevention Program funding on high risk populations based on local HIV prevalence. Jefferson County is a low prevalence county, so JCPH hasn t received direct State Department of Health (DOH) SEP funding since 2011. Currently, DOH has given each SEP a fixed budget and supply list from which we can order supplies. We expect this to continue for 2018. Jefferson County s syringe exchange program success is not easily measured in disease prevention numbers, but the number of clients seen and syringes exchanged reflect the disease transmission prevention capacity of this program. SEP utilization increased in, with 308 client visits and 91,290 syringes dispensed. See tables and graphs on the following pages for details. Naloxone is a medication used to reverse opioid overdose, providing time for transportation to the ER for additional treatment if needed. JCPH worked with the Center for Opioid Safety Education (COSE) at the University of Washington in and to develop protocols and training for a naloxone distribution program. JCPH started dispensing naloxone kits supplied by COSE in February,. COSE received a grant from SAMHSA in to be able to continue to supply naloxone to SEPs. We expect this supply to continue through 2018. In January, JCPH provided 40 Evzio kits (auto-injector naloxone product), and training for their use, to the Jefferson County Sheriff s Department. These kits were obtained through a Kaleo naloxone donation grant. JCPH distributed 135 naloxone kits in, along with training, to SEP clients, their friends, and family. Forty one of these kits were reported as used for treatment of an overdose. In, JCPH distributed 61 naloxone kits, six were reported as used for treatment of an overdose. Throughout staff continued to encourage uninsured clients to apply for health insurance through www.wahealthplanfinder.org/. Many clients signed up for Apple Health in 2014 and. Community Health Environmental Health Developmental Disabilities Water Quality 360-385-9400 360-385-9444 360-385-9401 (f) Always working for a safer and healthier community (f) 360-379-4487

2018 Goals Continue anonymous, safe, services to reduce the risk of HIV and hepatitis C infection in our communities by providing clean supplies, risk reduction education, referrals for healthcare and treatment services, promoting revisits by clients, and encouraging clients to tell others about SEP. Continue to educate clients on the importance of using each syringe one time only. Offer the naloxone overdose prevention program to clients at risk for opioid overdose and update program procedures as needed. Continue to inform clients at each visit of resources available at JCPH and in the community. Encourage uninsured clients to sign up for health insurance through www.wahealthplanfinder.org as long as this option is available. Refer clients internally for HIV and Hepatitis C testing, STD screening, and Family Planning services. If State DOH support for purchasing supplies is discontinued, explore other possible funding options. If SAMHSA funding for naloxone is discontinued, explore other possible funding options. If State support for purchasing supplies is discontinued, prioritize supplies to be stocked, keeping only those deemed most necessary to maintain safer practices among IDU clients. Inform clients of alternative safe materials, such as using plastic bottles for the collection of used syringes in lieu of sharps containers. Continue to advocate for increased access for opioid treatment, including local access to medicationassisted treatment (MAT). The lack of local access to MAT from providers that accept Medicaid is a recurring issue brought up by SEP clients. SEP staff will continue to request updates from the Community Health Improvement Plan (CHIP) Substance Abuse and Mental Health work group, and from the Olympic Community of Health (OCH) Regional Opioid Response Project. Annual SEP Report 2

Number of clinic visits Number of Syringes Exchanged Figure 1: Syringe Exchange Utilization, 2004 Number of client visits Number of syringes exchanged 400 350 300 250 200 150 100 50-24,585 18,060 13,716 17,905 21,133 64 36 58 65 70 9,156 14,044 65 81 17,405 17,726 142 24,596 150 185 42,809 35,328 350 238 47,790 242 91,290 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 308 100,000 90,000 80,000 70,000 60,000 50,000 40,000 30,000 20,000 10,000 - Table 1: Jefferson County SEP Clinic Visits/Demographics SEP Visits 1 New Clients Returning Client Visits 1 Secondary Exchange Visits 1 Client Visits 1 Client Visits 1 308 58 250 236 113 195 242 28 214 159 66 173 238 36 202 152 77 158 2014 350 50 300 227 199 145 2013 185 28 157 126 115 70 2012 150 18 132 96 NA NA 2011 142 19 123 110 NA NA 2010 81 13 68 40 NA NA 2009 65 12 53 35 NA NA 2008 68 6 64 67 NA NA 2007 65 9 56 58 NA NA 2006 54 8 50 49 NA NA 2005 36 6 30 29 NA NA 2004 64 12 48 45 NA NA 2003 63 9 55 53 NA NA 2002 41 11 29 25 NA NA 2001 16 6 9 5 NA NA 2000 14 3 7 3 NA NA Note: 1 Represents duplicate clients Annual SEP Report 3

Table 2: New Client Visits by Age and Gender < 20 yr 20-29 yr 30+ yr Total < 20 yr 20-29 yr 30+ yr Total 0 15 11 26 0 13 19 32 2 5 2 9 1 5 13 19 0 4 9 13 0 11 12 23 2014 2 7 11 20 3 8 18 29 2013 6 4 3 13 2 6 7 15 Table 3: Total Client Visits by Age < 20 years 20-29 years 30+ years 11 (4%) 142 (46%) 155 () 9 (4%) 71 () 159 (66%) 9 (4%) 68 (29%) 158 (67%) 2014 53 (15%) 100 (29%) 191 (56%) 2013 23 (12%) 77 (42%) 84 (46%) 7 Figure 2: SEP Participant Visits by Zip Code 34% 26% 2012 2013 2014 98368 Other within Jefferson County Outside Jefferson County Figure 3: SEP Participant Secondary Exchange 46% No secondary exchange 22% 22% Exchanging for one other person Exchanging for 2-5 other people Exchanging for 6+ other people 2012 2013 2014 Annual SEP Report 4

Percent of Visits with Drug Choice Figure 4: SEP Participant Reported Drug of Choice 56% 47% 34% 23% 19% 19% 18% 19% Meth Only Heroin Only Meth and Heroin 13% 7% 2% 2% 1% Other, including other opoiods Meth Heroin and Other Most participants reporting other for drug of choice report they are using prescription medications, usually opioids. 8 72% 76% Figure 5: SEP Reported Syringe Use, 69% 17% 15% 11% Each syringe used once Each syringe used twice Each syringe used 3+ times 4% 8% 8% 3% Unknown 8 7 49% 67% 64% 64% Each syringe used once Figure 6: SEP Reported Syringe Use, 2011 2014 22% 12% 25% 21% Each syringe used 2-5 times 3% 2% 1% 1% Each syringe used 6+ times 26% 22% 14% 7% Unknown 2011 2012 2013 2014 Annual SEP Report 5

Most participants reporting other for drug of choice report they are using prescription medications, usually opioids. Table 5: Naloxone Distribution and Training Provided First Naloxone Kit Naloxone Refill 1 Refills with known OD treatment reported Total Kits distributed 59 76 41 135 March-December 44 17 6 61 Note: 1 Many refill clients reported the first kit was given away to someone who needed it. Syringes Exchanged Table 4: Materials, Education, and Referrals Provided IDU Condoms/ Educational Prevention Latex Materials 3 Materials 1 Barriers 2 Provided Referral Information 4 Outreach Education 5 91,290 39,347 305 17 179 237 47,790 17,293 464 14 71 132 35,328 15,414 692 19 86 109 2014 42,809 18,373 625 52 139 177 2013 24,596 15,984 377 18 129 105 2012 17,405 11,535 406 28 128 90 2011 17,726 16,512 319 10 142 86 2010 9,156 11,024 102 7 67 29 2009 14,044 7,098 271 26 51 33 2008 21,330 7,941 140 32 35 32 2007 24,585 9,988 20 18 23 N/R 6 Notes 1 IDU Prevention Materials include: Tourniquets, cookers, cottons, sterile water, sharps containers, alcohol preps, antibiotic ointment, band aids and sterile pads for wounds, tape. Individual items are given on an as needed basis. 2 This number is for condoms dispensed in SEP only, condoms may also be picked up in the lobby. 3 Educational Materials include information on hepatitis, HIV, STDs, health alerts (ex. wound botulism, overdose), care of abscesses, street drugs, tattoo safety, needle reuse, IDU safety, domestic violence, immunizations, Apple Health application. 4 Referrals: Internal referrals include STD, HIV, and Hepatitis C testing, tuberculosis testing, family planning and immunizations. External referrals include drug treatment, medical care, mental health care, domestic violence, food, clothing, and shelter. 5 Outreach education is defined as face-to-face education on blood borne pathogens, risk reduction methods, safe injecting practices, overdose prevention, vein care, and other as needed. 6 N/R: Not reported 3/22/2018 Lisa McKenzie lmckenzie@co.jefferson.wa.us Annual SEP Report 6